Position history for BlackRock, Inc.'s holdings in TREVI THERAPEUTICS INC
BlackRock, Inc. holds 10.2M shares of TRVI (TREVI THERAPEUTICS INC), worth $122.2M as of 2026-Q1. The position was increased (+1.1% shares). TRVI represents 0.0% of BlackRock, Inc.'s portfolio.
Current Value
$122.2M
Current Shares
10.2M
Total Value Change
+$106M
Total Shares Change
+6.3M
Other major holders of TRVI: FMR LLC, VANGUARD GROUP INC, WELLINGTON MANAGEMENT GROUP LLP, MARSHALL WACE, LLP
Increased |
| 10.2M |
+1.1% |
| $122.2M |
| 0.0% |
| $12.26 |
30 |
| 2025-Q4 | Increased | 10.1M | +2.3% | $126.8M | 0.0% | $12.56 | 31 |
| 2025-Q3 | Increased | 9.9M | +20.7% | $90.6M | 0.0% | $8.95 | 36 |
| 2025-Q2 | Increased | 8.2M | +54.5% | $44.9M | 0.0% | $5.62 | 41 |
| 2025-Q1 | Increased | 5.3M | +35.2% | $33.4M | 0.0% | $6.50 | 37 |
| 2024-Q4 | New | 3.9M | - | $16.2M | 0.0% | $4.10 | 39 |